摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-Cyanobiphenyl-4'-yloxy)-6-(4-cyanobiphenyl-4'-yl) hexane

中文名称
——
中文别名
——
英文名称
1-(4-Cyanobiphenyl-4'-yloxy)-6-(4-cyanobiphenyl-4'-yl) hexane
英文别名
4-[4-[6-[4-(4-cyanophenyl)phenoxy]hexyl]phenyl]benzonitrile
1-(4-Cyanobiphenyl-4'-yloxy)-6-(4-cyanobiphenyl-4'-yl) hexane化学式
CAS
——
化学式
C32H28N2O
mdl
——
分子量
456.6
InChiKey
UWDYYKNPQUGZMH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.3
  • 重原子数:
    35
  • 可旋转键数:
    10
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    56.8
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Polarization-insensitive phase modulator
    申请人:OPTICA AMUKA (A.A.) LTD.
    公开号:US11327385B2
    公开(公告)日:2022-05-10
    An optical device (20) includes an electro-optical layer, including a liquid crystal material (24) with a heliconical structure having a pitch that is less than 250 nm and is modifiable by an electric field. An array of excitation electrodes (28) extends over the electro-optical layer. Control circuitry (23) is coupled to apply control voltage waveforms to the excitation electrodes and is configured to modify the control voltage waveforms so as to locally modify a molecule director angle of the heliconical structure and thus to generate a specified phase modulation profile in the electro-optical layer.
    一种光学设备(20)包括一个电光层,其中液晶材料(24)具有螺距小于 250 nm 的螺旋结构,并可通过电场进行调节。激发电极阵列(28)延伸到电光层上。控制电路(23)被耦合到激励电极上施加控制电压波形,并被配置为修改控制电压波形,以便局部修改螺旋结构的分子导向角,从而在电光层中产生指定的相位调制剖面。
  • BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA
    申请人:Merck Patent GmbH
    公开号:EP2870217B1
    公开(公告)日:2016-07-20
  • Bimesogenic Compounds and Mesogenic Media
    申请人:Merck Patent GmbH
    公开号:US20150175883A1
    公开(公告)日:2015-06-25
    The invention relates to bimesogenic compounds of formula I wherein R 11 , R 12 , MG 11 , MG 12 , X 11 , X 12 and Sp 1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.
  • FIELD INDUCED AND CONTROLLED HELICONICAL STRUCTURE OF CHOLESTERIC LIQUID CRYSTAL
    申请人:Kent State University
    公开号:US20160252755A1
    公开(公告)日:2016-09-01
    A liquid crystal cell includes substrates defining a gap and electrodes having one of (i) an in-plane geometry generating an electric field parallel with the substrates and (ii) a top-down geometry generating an electric field across the gap between the two spaced apart substrates. A liquid crystal material disposed in the gap between the substrates comprises a chiral nematic material formed by a mixture of: 1-(4-cyanobiphenyl-4′-yl)-6-(4-cyanobiphenyl-4′-yloxy)hexane (CB6OCB) or α,ω-bis(4,4-cyanobiphenyl)nonane (CB9CB) dimeric liquid crystal material; at least one additional dimeric liquid crystal material; and a chiral dopant. The liquid crystal material within an operational range of electric field applied by the electrodes exhibits a heliconical state with an oblique angle helicoid director whose helicoid axis is oriented parallel with the electric field and whose helicoid pitch is sized to provide diffraction or Bragg reflection of light in a spectral range of interest impinging on one of the substrates of the liquid crystal cell.
  • ELECTRICALLY TUNABLE LASER WITH CHOLESTERIC LIQUID CRYSTAL HELICONICAL STRUCTURE
    申请人:Kent State University
    公开号:US20180323570A1
    公开(公告)日:2018-11-08
    A lasing device includes an active layer comprising a cholesteric liquid crystal material and a laser dye, and a liquid crystal cell including spaced apart substrates defining a cell gap in which the active layer is disposed. The substrates include electrodes arranged to bias the active layer into an oblique helicoidal (Ch OH ) state. At least one substrate of the liquid crystal cell is optically transparent for a lasing wavelength range of the device.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫